[ 18 F]1f as OX1R selective radioligand and its nonselective analog [ 18 F]1c represent a solid basis for further developments toward suitable OXR PET ligands for brain imaging, especially through structural changes that induce lower blood-protein binding and the application of 18 F-labeling methods that generate fewer by-products and thus enable higher molar activities.